Original articleComparison of mitozantrone and epirubicin in advanced breast cancer
References (15)
- et al.
Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantrone
Eur J Cancer Clin Oncol
(1987) - et al.
A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast cancer
Clin Oncol
(1993) - et al.
A randomized trial comparing mitozantrone with doxorubicin in patients with Stage IV breast cancer
Invest New Drugs
(1985) - et al.
Randomized clinical trial comparing mitozantrone with doxorubicin in previously treated patients with metastatic breast cancer
J Clin Oncol
(1989) - et al.
A comparison of mitozantrone and doxorubicin in breast cancer
J Clin Oncol
(1986) - et al.
A randomized multicenter trial comparing mitozantrone, cyclophosphamide and fluorouracil with doxorubicin, cyclophosphamide and fluorouracil, in the therapy of metastatic breast carcinoma
J Clin Oncol
(1988) - et al.
Treatment of advanced breast cancer with Mitomycin-C, mitozantrone and methotrexate (3M) compared to vincristine, anthracycline and cyclophosphamide (VAC)
There are more references available in the full text version of this article.
Cited by (6)
Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model
2015, European Journal of Pharmaceutics and BiopharmaceuticsCitation Excerpt :In breast cancer chemotherapy anthracyclines are being used extensively. The use of MTO, an anthracenedione closely related to anthracyclines, however, has gained importance in the treatment of metastatic breast cancer [4,5] to decrease toxicity at similar therapeutic activity [6]. Nonetheless, MTO still exerts considerable toxicity [32], which should be further minimized while maintaining or even improving its therapeutic activity.
Topoisomerase inhibitors in metastatic breast cancer: Overview of current practice and future development
2013, Current Breast Cancer ReportsMultiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer
2008, Journal of the National Cancer Institute
Copyright © 1996 Published by Elsevier Ltd.